Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CTMX
FechaHoraFuenteTítuloSímboloCompañía
26/09/202215:32Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CTMXCytomX Therapeutics Inc
23/09/202215:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
12/09/202207:00GlobeNewswire Inc.CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody® Therapeutic BMS-986249NASDAQ:CTMXCytomX Therapeutics Inc
07/09/202217:05GlobeNewswire Inc.CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate (ADC) Programs Including Next Generation EpCAM-Targeting CX-2051NASDAQ:CTMXCytomX Therapeutics Inc
05/09/202218:15TipRanksCytomX Therapeutics (CTMX) Receives a Hold from Mizuho SecuritiesNASDAQ:CTMXCytomX Therapeutics Inc
12/08/202216:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
08/08/202205:20TipRanksWall Street Analysts Are Neutral on Top Healthcare PicksNASDAQ:CTMXCytomX Therapeutics Inc
05/08/202207:33TipRanksAnalysts Offer Insights on Healthcare Companies: Cigna (CI), Arrowhead Pharmaceuticals (ARWR) and CytomX Therapeutics (CTMX)NASDAQ:CTMXCytomX Therapeutics Inc
04/08/202215:15GlobeNewswire Inc.CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
04/08/202215:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
03/08/202207:00GlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming Virtual August Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
29/07/202215:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
28/07/202207:00GlobeNewswire Inc.CytomX Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022NASDAQ:CTMXCytomX Therapeutics Inc
25/07/202215:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTMXCytomX Therapeutics Inc
14/07/202205:35TipRanksCytomX Therapeutics (CTMX) Gets a Hold Rating from H.C. WainwrightNASDAQ:CTMXCytomX Therapeutics Inc
13/07/202215:05GlobeNewswire Inc.CytomX Therapeutics Provides Strategic UpdateNASDAQ:CTMXCytomX Therapeutics Inc
11/07/202205:18TipRanksAnalyst Explains Why They Downgraded Their Rating on CytomX Therapeutics (CTMX)NASDAQ:CTMXCytomX Therapeutics Inc
07/07/202203:15TipRanksWhy Did Mizuho Securities Downgrade CytomX Therapeutics’ Stock?NASDAQ:CTMXCytomX Therapeutics Inc
06/07/202215:05GlobeNewswire Inc.CytomX Therapeutics Announces Phase 2 Results for Praluzatamab Ravtansine in Breast CancerNASDAQ:CTMXCytomX Therapeutics Inc
16/06/202207:00GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantsNASDAQ:CTMXCytomX Therapeutics Inc
01/06/202207:00GlobeNewswire Inc.CytomX Therapeutics to Present at Jefferies 2022 Global Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
26/05/202207:00GlobeNewswire Inc.CytomX Therapeutics Announces First Patient Dosed with CX-904 in Phase 1 Study in Patients with Advanced Solid TumorsNASDAQ:CTMXCytomX Therapeutics Inc
05/05/202215:15GlobeNewswire Inc.CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
28/04/202207:00GlobeNewswire Inc.CytomX Therapeutics to Report First Quarter 2022 Financial Results on May 5, 2022NASDAQ:CTMXCytomX Therapeutics Inc
27/04/202215:25Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTMXCytomX Therapeutics Inc
27/04/202215:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CTMXCytomX Therapeutics Inc
14/04/202215:15GlobeNewswire Inc.CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
28/03/202215:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
23/03/202215:15GlobeNewswire Inc.CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
17/03/202207:00GlobeNewswire Inc.CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program at AACR Annual Meeting 2022NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX